en

Sign up
Investments involve risks and are not suitable for all investors.

LLY

904.26

+0.95%↑

UNH

562.18

-0.6%↓

NVO

112.01

-0.39%↓

JNJ

160.15

-0.86%↓

ABBV

189.51

-0.07%↓

LLY

904.26

+0.95%↑

UNH

562.18

-0.6%↓

NVO

112.01

-0.39%↓

JNJ

160.15

-0.86%↓

ABBV

189.51

-0.07%↓

LLY

904.26

+0.95%↑

UNH

562.18

-0.6%↓

NVO

112.01

-0.39%↓

JNJ

160.15

-0.86%↓

ABBV

189.51

-0.07%↓

LLY

904.26

+0.95%↑

UNH

562.18

-0.6%↓

NVO

112.01

-0.39%↓

JNJ

160.15

-0.86%↓

ABBV

189.51

-0.07%↓

LLY

904.26

+0.95%↑

UNH

562.18

-0.6%↓

NVO

112.01

-0.39%↓

JNJ

160.15

-0.86%↓

ABBV

189.51

-0.07%↓

Home・Stock List・Ascendis Pharma A-S ADR
Search

Ascendis Pharma A-S ADR

Open

Sector Healthcare

126.29 -4.51

Strong Buy

Price update 29 Oct 2024, 16:24 UTC

BuySell

Overview

Share price change

24h

Current

Min

125.75

Max

130.79

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+51.66 upside

Dividends

By Dow Jones

Next Earnings

5 Nov 2024

News Sentiment

By Acuity

50%

50%

190 / 389 Healthcare

Technical Score

By Trading Central

Confidence

Bearish Evidence

127.69 / 130.31 Support & Resistance

Ascendis Pharma A-S ADR Chart

Past performance is not a reliable indicator of future results.

Related News

12 Aug 2024, 13:03 UTC

Major Market Movers

Ascendis Pharma Shares Climb on U.S. FDA Approval for Hypoparathyroidism Treatment Yorvipath

DJ

Read

Peer Comparison

Price change

Ascendis Pharma A-S ADR Forecast

Price Target

By TipRanks

51.66% upside

12 Months Forecast

Average 196.31 USD  51.66%

High 289 USD

Low 160 USD

Based on 13 Wall Street analysts offering 12 month price targets forAscendis Pharma A-S ADR - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

13 ratings

12

Buy

1

Hold

0

Sell

Based on 13 analysts giving stock ratings to Ascendis Pharma A-S ADR - Dist in the past 3 months.

Technical Score

By Trading Central

127.69 / 130.31Support & Resistance

Short Term

Bearish Evidence

Recent bearish events outweigh bullish events.

Intermediate Term

Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Long Term

Weak Bearish Evidence

Recent bearish events outweigh bullish events.

Sentiment

By Acuity

190 / 389 Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Financials

$

Other stocks from the sector

LLY

Eli Lilly and Co.

904.26

↑ +0.95%

UNH

UnitedHealth Group Inc

562.18

↓-0.6%

NVO

Novo Nordisk A-S

112.01

↓-0.39%

JNJ

Johnson and Johnson

160.15

↓-0.86%

ABBV

AbbVie Inc

189.51

↓-0.07%